Zimmer Biomet Holdings Analyst Price Targets

Wall Street analyst price targets and consensus rating for Zimmer Biomet Holdings (ZBH).

Price Target Range — 11 Quarters

Analyst Consensus — 22 Analysts

2S.Buy

7Buy

13Hold

Consensus RatingNeutral# Analysts22Avg. Consensus PT$107Upside to Avg. PT+19.8%

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 7, 2026	Barclays	Christopher Pasquale	Initiate	Equal-Weight	$100
Aug 10, 2026	Canaccord Genuity	Caitlin Roberts	PT Raise	Hold	$83→$100
Aug 7, 2026	Truist Securities	Richard Newitter	PT Raise	Hold	$92→$106
Aug 6, 2026	RBC Capital	Shagun Singh	PT Raise	Outperform	$101→$110
Aug 6, 2026	Bernstein	Lee Hambright	PT Raise	Market Perform	$91→$93
Aug 6, 2026	Stifel	Rick Wise	PT Raise	Buy	$105→$110
Jul 28, 2026	UBS	Patrick Wood	Assumes	Sell→Buy	$89→$115
Jul 9, 2026	BMO Capital	Vik Chopra	Initiate	Outperform→Market Perform	$95
Jul 6, 2026	Evercore ISI Group	Vijay Kumar	PT Cut	Outperform	$120→$110
May 28, 2026	Citigroup	Joanne Wuensch	PT Cut	Neutral	$95→$93
Apr 29, 2026	JP Morgan	Robbie Marcus	PT Cut	Neutral	$100→$95
Apr 29, 2026	Citigroup	Joanne Wuensch	PT Cut	Neutral	$98→$95
Apr 29, 2026	Citizens	David Turkaly	PT Cut	Market Outperform	$120→$105
Apr 29, 2026	Wells Fargo	Larry Biegelsen	PT Cut	Equal-Weight	$98→$90
Apr 29, 2026	Barclays	Matt Miksic	PT Cut	Underweight	$100→$94
Apr 29, 2026	Truist Securities	Richard Newitter	PT Cut	Hold	$98→$92
Apr 29, 2026	Stifel	Rick Wise	PT Cut	Buy	$110→$105
Apr 13, 2026	Leerink Partners	Mike Kratky	Initiate	Market Perform	$101
Mar 23, 2026	BTIG	Ryan Zimmerman	Downgrade	Buy→Neutral	—
Feb 12, 2026	Barclays	Matt Miksic	PT Cut	Underweight	$104→$100

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Barclays Initiates Coverage On Zimmer Biomet Holdings with Equal-Weight Rating, Announces Price Target of $100

Barclays analyst Christopher Pasquale initiates coverage on Zimmer Biomet Holdings (NYSE:ZBH) with a Equal-Weight rating and announces Price Target of $100.

Benzinga Newsdesk

PRO
Canaccord Genuity Maintains Hold on Zimmer Biomet Holdings, Raises Price Target to $100

Canaccord Genuity analyst Caitlin Roberts maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Hold and raises the price target from $83 to $100.

Benzinga Newsdesk

PRO
Truist Securities Maintains Hold on Zimmer Biomet Holdings, Raises Price Target to $106

Truist Securities analyst Richard Newitter maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Hold and raises the price target from $92 to $106.

Benzinga Newsdesk

PRO
RBC Capital Maintains Outperform on Zimmer Biomet Holdings, Raises Price Target to $110

RBC Capital analyst Shagun Singh maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Outperform and raises the price target from $101 to $110.

Benzinga Newsdesk

PRO
Bernstein Maintains Market Perform on Zimmer Biomet Holdings, Raises Price Target to $93

Bernstein analyst Lee Hambright maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Market Perform and raises the price target from $91 to $93.

Benzinga Newsdesk

PRO
Stifel Maintains Buy on Zimmer Biomet Holdings, Raises Price Target to $110

Stifel analyst Rick Wise maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Buy and raises the price target from $105 to $110.

Benzinga Newsdesk

Zimmer Biomet Holdings Inc

뉴스

파트너 / 기고자

벤징가 글로벌

Zimmer Biomet Holdings Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Barclays Initiates Coverage On Zimmer Biomet Holdings with Equal-Weight Rating, Announces Price Target of $100

PRO
Canaccord Genuity Maintains Hold on Zimmer Biomet Holdings, Raises Price Target to $100

PRO
Truist Securities Maintains Hold on Zimmer Biomet Holdings, Raises Price Target to $106

PRO
RBC Capital Maintains Outperform on Zimmer Biomet Holdings, Raises Price Target to $110

PRO
Bernstein Maintains Market Perform on Zimmer Biomet Holdings, Raises Price Target to $93

PRO
Stifel Maintains Buy on Zimmer Biomet Holdings, Raises Price Target to $110

People Also Watch

People Also Watch

Zimmer Biomet Holdings Inc

뉴스

파트너 / 기고자

벤징가 글로벌

Zimmer Biomet Holdings Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROBarclays Initiates Coverage On Zimmer Biomet Holdings with Equal-Weight Rating, Announces Price Target of $100

PROCanaccord Genuity Maintains Hold on Zimmer Biomet Holdings, Raises Price Target to $100

PROTruist Securities Maintains Hold on Zimmer Biomet Holdings, Raises Price Target to $106

PRORBC Capital Maintains Outperform on Zimmer Biomet Holdings, Raises Price Target to $110

PROBernstein Maintains Market Perform on Zimmer Biomet Holdings, Raises Price Target to $93

PROStifel Maintains Buy on Zimmer Biomet Holdings, Raises Price Target to $110

People Also Watch

People Also Watch

PRO
Barclays Initiates Coverage On Zimmer Biomet Holdings with Equal-Weight Rating, Announces Price Target of $100

PRO
Canaccord Genuity Maintains Hold on Zimmer Biomet Holdings, Raises Price Target to $100

PRO
Truist Securities Maintains Hold on Zimmer Biomet Holdings, Raises Price Target to $106

PRO
RBC Capital Maintains Outperform on Zimmer Biomet Holdings, Raises Price Target to $110

PRO
Bernstein Maintains Market Perform on Zimmer Biomet Holdings, Raises Price Target to $93

PRO
Stifel Maintains Buy on Zimmer Biomet Holdings, Raises Price Target to $110